Scotia Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-30,000
Closed -$3.46M 793
2016
Q4
$3.46M Hold
30,000
0.06% 218
2016
Q3
$3.54M Hold
30,000
0.07% 204
2016
Q2
$3.64M Hold
30,000
0.07% 180
2016
Q1
$3.25M Hold
30,000
0.07% 170
2015
Q4
$3.08M Hold
30,000
0.07% 203
2015
Q3
$2.8M Hold
30,000
0.06% 208
2015
Q2
$2.92M Buy
+30,000
New +$3M 0.06% 224

Other funds holding JNJ

Scotia Capital's JNJ Position: Q1 2026 in Review

Scotia Capital reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q1 2026, selling an estimated $20.8M and leaving 1,231,920 shares worth $301M. The position accounts for 1.24% of the portfolio, ranked #23.

Scotia Capital first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Scotia Capital held 1,231,920 shares of Johnson & Johnson worth $301M as of Q1 2026.
  • Scotia Capital sold 89,336 Johnson & Johnson shares in Q1 2026, an estimated $20.8M.
  • Johnson & Johnson made up 1.24% of Scotia Capital's portfolio in Q1 2026, its #23 holding.
  • Scotia Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.